Apart from the JAK/STAT3 pathway, IL-6 can also exacerbate the intestinal inflammatory response in patients and promote colitis-associated colorectal cancer by regulation of Th17 and Treg cell proliferation and function (Wang et al. 2023a, b, c, d, e). Here, IL6 is linked to colitis.